Internet-delivered CBT for Adolescents With Obsessive-Compulsive Disorder - a Pilot Study

June 27, 2014 updated by: Eva Serlachius

Internet-delivered Cognitive Behavior Therapy for Adolescents With Obsessive-Compulsive Disorder - a Pilot Study

The main goal of this trial is to study the feasibility and effectiveness of internet-delivered cognitive behavior therapy for adolescents with obsessive-compulsive disorder.

Study Overview

Study Type

Interventional

Enrollment (Actual)

21

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Stockholm, Sweden
        • Karolinska insititute

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

12 years to 17 years (CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • a primary diagnosis of OCD as defined by DSM-IV TR
  • a total score of above 15 on the CY-BOCS
  • age between 12 and 17 years
  • ability to read and write Swedish
  • daily access to the internet
  • a parent that is able to co-participate in the treatment
  • Participants on psychotropic medication must have been on a stable dose for the last 6 weeks prior to baseline assessment
  • signed informed consent

Exclusion Criteria:

  • diagnosed autism spectrum disorder, psychosis or bipolar disorder
  • suicidal ideation
  • ongoing substance dependence
  • subject not able to read or understand the basics of the ICBT self-help material
  • completed CBT for OCD within last 12 months (defined as at least 5 sessions CBT including exposure and response prevention)
  • ongoing psychological treatment for OCD or another anxiety disorder

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: internet-delivered cognitive behavior therapy
Participants will be assigned to a 12 weeks internet-delivered cognitive behavior therapy program including therapist contact via an internet platform and telephone.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Children's Yale Brown Obsessive Compulsive Scale, CY-BOCS
Time Frame: Baseline, 12 weeks after treatment starts, 3 and 6 months after treatment has ended
Change from Baseline of obsessions and compulsions after 12 weeks and at 3- and 6 months after treatment.
Baseline, 12 weeks after treatment starts, 3 and 6 months after treatment has ended

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Spence Child Anxiety Scale - Child and Parent version
Time Frame: Baseline, 12 weeks after treatment starts, 3 and 6 months after treatment has ended
Spence Child Anxiety Scale - Child and Parent version (SCAS/P, Spence, 1998) will be used as a child and parent self-report measure of anxiety related psychopathology.
Baseline, 12 weeks after treatment starts, 3 and 6 months after treatment has ended
Child Depression Inventory
Time Frame: Baseline, 12 weeks after treatment starts, 3 and 6 months after treatment has ended
Symptom severity of depression in the adolescent will be assessed with Child Depression Inventory (CDI, Kovacs, 1985).
Baseline, 12 weeks after treatment starts, 3 and 6 months after treatment has ended
Strengths Difficulties Questionnaire
Time Frame: Baseline, 12 weeks after treatment starts, 3 and 6 months after treatment has ended
Strengths Difficulties Questionnaire (SDQ, Goodman, 1997) is a widely used self- and parent-report behavioral screening questionnaire with six subscales: emotional problems, conduct problems, hyperactivity-inattention, peer problems, prosocial behavior
Baseline, 12 weeks after treatment starts, 3 and 6 months after treatment has ended
Children's Obsessional Compulsive Inventory Revised
Time Frame: Baseline, 12 weeks after treatment starts, 3 and 6 months after treatment has ended
The Children's Obsessional Compulsive Inventory Revised, (CHOCI-R, Shafran et al., 2003) is a self- and parent-report measure of pediatric OCD symptom severity.
Baseline, 12 weeks after treatment starts, 3 and 6 months after treatment has ended
Child Obsessive-Compulsive Impact Scale - Revised
Time Frame: Baseline, 12 weeks after treatment starts, 3 and 6 months after treatment has ended
Child Obsessive-Compulsive Impact Scale - Revised (COIS-R, Piacentini, Peris, Bergman, Chang, & Jaffer, 2007) is a self- and parent-report scale of OCD symptom impact on everyday life.
Baseline, 12 weeks after treatment starts, 3 and 6 months after treatment has ended

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient Health Questionnaire PHQ-9
Time Frame: Baseline, 12 weeks after treatment starts, 3 and 6 months after treatment has ended
Patient Health Questionnaire PHQ-9 (Kroenke, Spitzer, & Williams, 2001) is a brief self-report measure of depressive symptoms in adults. PHQ-9 will be used to measure parental depressive symptoms.
Baseline, 12 weeks after treatment starts, 3 and 6 months after treatment has ended
GAD-7
Time Frame: Baseline, 12 weeks after treatment starts, 3 and 6 months after treatment has ended
GAD-7 (Spitzer, Kroenke, Williams, & Löwe, 2006) is a brief self-report measure of symptoms of general anxiety in adults. GAD-7 will be used to measure symptoms of anxiety in the parents.
Baseline, 12 weeks after treatment starts, 3 and 6 months after treatment has ended
Obsessive Compulsive Inventory - Revised
Time Frame: Baseline, 12 weeks after treatment starts, 3 and 6 months after treatment has ended
Obsessive Compulsive Inventory - Revised (OCI-R, Foa et al., 2002) is a reliable and valid 18-item self-report scale for screening of OCD in adults and will be used to measure parental OC symptoms of both parents.
Baseline, 12 weeks after treatment starts, 3 and 6 months after treatment has ended
Family Accommodation Scale, Parent-Report
Time Frame: Baseline, 12 weeks after treatment starts, 3 and 6 months after treatment has ended
Family Accommodation Scale, Parent-Report (FAS-PR, Flessner et al., 2009). The parent-report version of the FAS consists of 12 items focusing on accommodation behaviors of parents with a child with OCD.
Baseline, 12 weeks after treatment starts, 3 and 6 months after treatment has ended

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Collaborators

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2013

Primary Completion (ACTUAL)

January 1, 2014

Study Completion (ACTUAL)

January 1, 2014

Study Registration Dates

First Submitted

February 17, 2013

First Submitted That Met QC Criteria

March 11, 2013

First Posted (ESTIMATE)

March 13, 2013

Study Record Updates

Last Update Posted (ESTIMATE)

June 30, 2014

Last Update Submitted That Met QC Criteria

June 27, 2014

Last Verified

June 1, 2014

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obsessive-Compulsive Disorder

Clinical Trials on Internet-delivered Cognitive Behavior Therapy

3
Subscribe